L-asparaginase biosimilar (Chandra Bhagat Pharma)

L-天冬酰胺酶生物类似药 (Chandra Bhagat Pharma)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameL-asparaginase biosimilar (Chandra Bhagat Pharma)
Drug Alias NameL-天冬酰胺酶生物仿制药 (Chandra Bhagat Pharma)
ClassificationBiologics > Protein drugs > Enzyme > Non-recombinant enzymeBiologics > Biosimilar
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsNeoplasms
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/01/01
Country/TerritoryIndia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChandra Bhagat Pharma(Cbc)
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XX02
Related LinksN/A